1)辻井博彦・鎌田 正・溝江純悦・他:重粒子線治療研究の過去,現在,未来—放医研における重粒子線治療の臨床成果.放射線科学50:5-19,2007
2)小野田貴・小林 奈・小林 健・他:涙道癌に陽子線治療を施行した1例.臨眼69:1531-1534,2015
3)河内 清:重粒子線治療とは その特徴と可能性.医学のあゆみ196:771-774,2001
4)石川 仁・大西かよ子・粟飯原輝人・他:頭頸部癌に対する低侵襲性治療の新展開 放射線治療.日本耳鼻咽喉科学会会報118:1399-1405,2015
5)Jeganathan VS, Wirth A, MacManus MP et al:Ocular risks from orbital and periorbital radiation therapy:a critical review. Int J Radiat Oncol Biol Phys 79:650-659, 2001
6)Stallard HB:Radiant energy as(a)a pathogenic(b)a therapeutic agent in ophthalmic disorders. Br J Ophthalmol 6(suppl):1-126, 1933
7)Nakissa N, Rubin P, Strohl R et al:Ocular and orbital complications following radiation therapy of paranasal sinus malignancies and review of literature. Cancer 51:980-986, 1983
8)Lopez PF, Sternberg P Jr, Dabbs CK et al:Bone marrow transplant retinopathy. Am J Ophthalmol 112:635-646, 1991
9)Ferguson I, Huecker J, Huang J et al:Risk factors for radiation-induced optic neuropathy:a case-control study. Clin Exp Ophthalmol 45:592-597, 2017
10)Kline LB, Kim JY, Ceballos R:Radiation optic neuropathy. Ophthalmology 92:1118-1126, 1985
11)Roden D, Bosley TM, Fowble B et al:Delayed radiation injury to the retrobulbar optic nerves and chiasm. Clinical syndrome and treatment with hyperbaric oxygen and corticosteroids. Ophthalmology 97:346-351, 1990
12)Brown GC, Shields JA, Sanborn G et al:Radiation optic neuropathy. Ophthalmology 89:1489-1493, 1982
13)Moiseenko V, Song WY, Mell LK et al:A comparison of dose-response characteristics of four NTCP models using outcomes of radiation-induced optic neuropathy and retinopathy. Radiat Oncol 6:61, 2011
14)Jiang GL, Tucker SL, Guttenberger R et al:Radiation-induced injury to the visual pathway. Radiother Oncol 30:17-25, 1994